Haemoglobin-based erythrocyte transfusion substitutes
Author:
- 1 September 2001
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 1 (5) , 831-843
Abstract
Concerns about the infectious and immunosuppressive risks of allogeneic blood products persist, and the increased disproportion of blood donation and consumption has reinforced the search for alternative erythrocyte transfusion strategies in recent years. With the absence of problems such as nephro-toxicity, increased colloid osmotic pressure and sudden renal clearance, modern haemoglobin based oxygen carriers (HBOC) have shown their effectiveness and tolerability in numerous animal and several clinical studies. HBOC can be infused without prior cross-matching and are now available as stable formulations with long shelf-life. Most clinical studies have been performed with human cross-linked haemoglobin (DCLHb) but all trials were stopped two years ago because of an increased mortality in two clinical trials in patients who received DCLHb after stroke and multiple injury shock. However, experimental trials in animals are in progress with DCLHb and recombinant human haemoglobin. In contrast, Phase III studi...Keywords
This publication has 75 references indexed in Scilit:
- EditorialsThe Journal of Bone and Joint Surgery. British volume, 1998
- Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humansCritical Care Medicine, 1996
- Epidemiology of red blood cell utilizationTransfusion Medicine Reviews, 1996
- Comparison of the efficacy of blood and polyethylene glycol‐hemoglobin in recovery of newborn piglets from hemorrhagic hypotension: effect on blood pressure, cortical oxygen, and extracellular dopamine in the brainTransfusion, 1995
- Epidemiology of blood transfusionTransfusion, 1994
- Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgeryThe Lancet, 1993
- Collection and transfusion of blood and blood components in the United States, 1989Transfusion, 1993
- The Declining Risk of Post-Transfusion Hepatitis C Virus InfectionNew England Journal of Medicine, 1992
- Ultrapure, stroma-free, polymerized bovine hemoglobin solution: Evaluation of renal toxicityJournal of Surgical Research, 1989
- A clinical safety trial of stroma‐free hemoglobinClinical Pharmacology & Therapeutics, 1978